Registration Decision RD2021-01, Trifludimoxazin, Vulcarus and Voraxor
This decision is consistent with the Proposed Registration Decision PRD2020-15, Trifludimoxazin, Vulcarus and Voraxor, which contains a detailed evaluation of the information submitted in support of this registration.
- Publisher
- Health Canada
- Resources
- 2
- Catalogue metadata updated
- 2023-03-27
Data overview
- Formats
- HTML
- File languages
- English, French